TECTONIC THERAPEUTIC, INC. Increase (Decrease) in Other Noncurrent Assets
TECTONIC THERAPEUTIC, INC. (TECX) reported Increase (Decrease) in Other Noncurrent Assets of -$14.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$37.00K, a 716.67% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $23.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$14.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $5.00K, a 99.14% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$17.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was -$544.00K, a 10980.00% decline from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was $5.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$14.00K 10-Q · filed 2026-08-06 | -$28.00K derived: sum of 3 quarters · filed 2026-08-06 | -$23.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $23.00K 10-Q · filed 2026-05-07 | $9.00K derived: sum of 2 quarters · filed 2026-05-07 | $14.00K derived: sum of 3 quarters · filed 2026-05-07 | $20.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.00K derived: sum of 2 quarters · filed 2026-02-26 | -$3.00K derived: sum of 3 quarters · filed 2026-08-06 | -$17.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $11.00K derived: sum of 2 quarters · filed 2026-08-06 | -$3.00K 10-Q · filed 2025-11-06 | -$707.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$8.00K 10-Q · filed 2026-08-06 | -$712.00K derived: sum of 3 quarters · filed 2026-08-06 | -$130.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$14.00K 10-Q · filed 2026-05-07 | -$718.00K derived: sum of 2 quarters · filed 2026-05-07 | -$136.00K derived: sum of 3 quarters · filed 2026-05-07 | -$534.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$704.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$122.00K derived: sum of 2 quarters · filed 2026-02-26 | -$520.00K derived: sum of 3 quarters · filed 2026-02-26 | -$544.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $582.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $184.00K derived: sum of 2 quarters · filed 2025-11-06 | $160.00K 10-Q · filed 2025-11-06 | $158.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$398.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$422.00K 10-Q · filed 2025-08-07 | -$424.00K derived: sum of 3 quarters · filed 2025-08-07 | -$431.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$24.00K 10-Q · filed 2025-05-08 | -$26.00K derived: sum of 2 quarters · filed 2025-05-08 | -$33.00K derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$9.00K derived: sum of 2 quarters · filed 2025-03-20 | $5.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $7.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $14.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |